Cancer-associated unsuspected pulmonary embolism

Area of Science:

• Oncology
• Radiology
• Pulmonology

Background:

• Clinically unsuspected pulmonary embolism (UPE) is frequently detected in cancer patients via routine CT scans.
• The incidence of UPE, estimated at 1-5%, may be underestimated and is rising with advanced imaging.
• UPE symptoms can be mistaken for cancer progression or treatment side effects, delaying diagnosis.

Purpose of the Study:

• To review the incidence, characteristics, and clinical implications of UPE in cancer patients.
• To evaluate current treatment guidelines and evidence for UPE management in this population.

Main Methods:

• Review of existing literature on UPE in cancer patients.
• Analysis of radiologic features and clinical outcomes of UPE.
• Comparison of UPE with symptomatic pulmonary embolism (PE) outcomes and treatment.

Main Results:

• UPE is found in 1-5% of cancer patients, often with symptoms misattributed to cancer.
• Radiologic findings of UPE resemble symptomatic PE, with central or bilateral involvement common.
• UPE carries risks of recurrence, bleeding, and mortality comparable to symptomatic PE.

Conclusions:

• UPE in cancer patients is a significant condition requiring careful consideration.
• Current guidelines advocate anticoagulation for UPE, mirroring symptomatic PE treatment.
• Further research is needed to refine treatment strategies, especially for subgroups like sub-segmental UPE.